Long-term effectiveness and safety of daily growth hormone therapy in Japanese children with Noonan syndrome: a post-marketing surveillance study.
- DOI
- 10.1507/endocrj.ej25-0116
- Published
- 2026 Feb 2
- Container
- Endocrine journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1507/endocrj.ej25-0116,
title = {Long-term effectiveness and safety of daily growth hormone therapy in Japanese children with Noonan syndrome: a post-marketing surveillance study.},
author = {Muroya K and Kawai M and Yamagishi H and Endo T and Pietropoli A and Ferran JM and Horikawa R},
year = {2026},
journal = {Endocrine journal},
doi = {10.1507/endocrj.ej25-0116},
url = {https://doi.org/10.1507/endocrj.ej25-0116}
}RIS
TY - JOUR TI - Long-term effectiveness and safety of daily growth hormone therapy in Japanese children with Noonan syndrome: a post-marketing surveillance study. AU - Muroya K AU - Kawai M AU - Yamagishi H AU - Endo T AU - Pietropoli A AU - Ferran JM AU - Horikawa R PY - 2026 JO - Endocrine journal DO - 10.1507/endocrj.ej25-0116 UR - https://doi.org/10.1507/endocrj.ej25-0116 ER -
APA
K, M., M, K., H, Y., T, E., A, P., JM, F., & R, H. (2026). Long-term effectiveness and safety of daily growth hormone therapy in Japanese children with Noonan syndrome: a post-marketing surveillance study.. Endocrine journal. https://doi.org/10.1507/endocrj.ej25-0116
Source records
- pubmed · retrieved 2026-09-25T16:27:59.851Z